Drugs / CNT-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02502578 | Sep 2015 → Jun 2016 | idiopathic triglyceride deposit cardiomyovasculopathy | Osaka University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CNT-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02502578 ↗ |
| Route | Oral | “CNT-01 500mg orally three times daily for 14 days” NCT02502578 ↗ |